|
Recipients of solid organ transplants commonly experience hyperkalemia, limiting use of pharmacotherapy in those patients. Hyperkalemia is associated with multifactorial causes, including kidney dysfunction, calcineurin inhibitor use, and infection prophylaxis. The effect of sodium zirconium cyclosilicate on potassium in the general population has been studied; however, the impact of SZ-9 on immunosuppression in transplant recipients is unknown.
|